Details for Patent: 7,700,076

Which drugs does patent 7,700,076 protect, and when does it expire?

Patent 7,700,076 protects FINACEA and is included in one NDA.

This patent has one hundred and thirty-seven patent family members in twenty countries.

Summary for Patent: 7,700,076

Title:	Penetrating pharmaceutical foam
Abstract:	The invention relates to an alcohol-free cosmetic or pharmaceutical foam composition comprising water, a hydrophobic solvent, a surface-active agent, a gelling agent, an active component selected from the group of urea, hydroxy acid and a therapeutic enhancer and a propellant. The foam further comprises active agents and excipients with therapeutic properties having enhanced skin penetration.
Inventor(s):	Dov Tamarkin, Doron Friedman, Meir Eini
Assignee:	Vyne Therapeutics Inc
Application Number:	US10/922,358
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,700,076
Patent Claim Types: see list of patent claims	Composition; Compound; Delivery;

Drugs Protected by US Patent 7,700,076

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Leo Pharma As	FINACEA	azelaic acid	AEROSOL, FOAM;TOPICAL	207071-001	Jul 29, 2015		RX	Yes	Yes	7,700,076		Y

Foreign Priority and PCT Information for Patent: 7,700,076

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Israel	152486	Oct 25, 2002

International Family Members for US Patent 7,700,076

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2003279493
Australia	2004261063
Australia	2004266502
Australia	2004313285